312 related articles for article (PubMed ID: 11563538)
1. Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells.
Candussio L; Crivellato E; Rosati AM; Klugmann FB; Granzotto M; Giraldi T; Decorti G
Histochem J; 2001 May; 33(5):259-66. PubMed ID: 11563538
[TBL] [Abstract][Full Text] [Related]
2. Bodipy-FL-verapamil: a fluorescent probe for the study of multidrug resistance proteins.
Rosati A; Candussio L; Crivellato E; Klugmann FB; Giraldi T; Damiani D; Michelutti A; Decorti G
Cell Oncol; 2004; 26(1-2):3-11. PubMed ID: 15371652
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.
Crivellato E; Candussio L; Rosati AM; Decorti G; Klugmann FB; Mallardi F
Histochem J; 1999 Oct; 31(10):635-43. PubMed ID: 10576412
[TBL] [Abstract][Full Text] [Related]
4. The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1.
Crivellato E; Candussio L; Rosati AM; Bartoli-Klugmann F; Mallardi F; Decorti G
J Histochem Cytochem; 2002 May; 50(5):731-4. PubMed ID: 11967284
[TBL] [Abstract][Full Text] [Related]
5. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.
Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M
Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417
[TBL] [Abstract][Full Text] [Related]
6. Transport of doxorubicin in mast cell granules and the effect of the calcium antagonist verapamil.
Candussio L; Decorti G; Crivellato E; Rosati AM; Traversa U; Klugmann FB
Anticancer Res; 1999; 19(2A):1101-8. PubMed ID: 10368660
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
9. Monensin and verapamil do not alter intracellular localisation of daunorubicin in multidrug resistant human KB cells.
Wood DJ; Rumsby MG; Warr JR
Cancer Lett; 1996 Nov; 108(1):41-7. PubMed ID: 8950207
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes.
Declèves X; Regina A; Laplanche JL; Roux F; Boval B; Launay JM; Scherrmann JM
J Neurosci Res; 2000 Jun; 60(5):594-601. PubMed ID: 10820430
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
Siegsmund MJ; Kreukler C; Steidler A; Nebe T; Köhrmann KU; Alken P
Urol Res; 1997; 25(1):35-41. PubMed ID: 9079744
[TBL] [Abstract][Full Text] [Related]
12. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
13. Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein.
Ayesh S; Litman T; Stein WD
Recept Channels; 1997; 5(3-4):175-83. PubMed ID: 9606721
[TBL] [Abstract][Full Text] [Related]
14. Expression of MRP1 and related transporters in human lung cells in culture.
Lehmann T; Köhler C; Weidauer E; Taege C; Foth H
Toxicology; 2001 Oct; 167(1):59-72. PubMed ID: 11557130
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
[TBL] [Abstract][Full Text] [Related]
18. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
Benderra Z; Morjani H; Trussardi A; Manfait M
Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
[TBL] [Abstract][Full Text] [Related]
19. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
[TBL] [Abstract][Full Text] [Related]
20. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells.
Regina A; Koman A; Piciotti M; El Hafny B; Center MS; Bergmann R; Couraud PO; Roux F
J Neurochem; 1998 Aug; 71(2):705-15. PubMed ID: 9681461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
